Per NRG è uscito un nuovo SEC Filing che allego ma non dice niente di nuovo e riassume la situazione di GenOn Energy:
As disclosed in Item 15 - Note 1, Nature of Business, and Note 12, Debt and Capital Leases, to the Consolidated Financial Statements, $691 million of GenOn's Senior Notes, excluding $8 million of associated premiums, are current within the GenOn consolidated balance sheet as of December 31, 2016 and are due on June 15, 2017. GenOn's future profitability continues to be adversely affected by (i) a sustained decline in natural gas prices and its resulting effect on wholesale power prices and capacity prices, and (ii) the inability of GenOn Mid-Atlantic and REMA to make distributions of cash and certain other restricted payments to GenOn. Based on current projections, GenOn is not expected to have sufficient liquidity to repay the Senior Notes due in June 2017. As a result of these factors, there is substantial doubt about GenOn's ability to continue as a going concern. As a result of the substantial doubt about GenOn’s ability to continue as a going concern, along with additional factors, there is substantial doubt about certain of GenOn’s subsidiaries’ ability to continue as a going concern.
The Company, GenOn's parent company, has no obligation to provide any financial support to GenOn other than under the secured intercompany revolving credit agreement between the Company and GenOn and NRG Americas. As of December 31, 2016, $228 million was available to be used by GenOn under the $500 million revolving credit agreement. As controlled group members, ERISA requires that NRG and GenOn are jointly and severally liable for the NRG Pension Plan for Bargained Employees and the NRG Pension Plan, including the pension liabilities associated with GenOn employees.
GenOn is currently considering all options available to it, including negotiations with creditors, refinancing the GenOn Senior Notes, potential sales of certain generating assets as well as the possibility for a need to file for protection under Chapter 11 of the U.S. Bankruptcy Code. During 2016, GenOn appointed two independent directors, retained advisors and established a separate audit committee as part of this process. Any resolution may have a material impact on the Company's statement of operations, cash flows and financial position.
As of December 31, 2016, GenOn represents 15.6% of the Company's consolidated total assets, 16.9% of the Company's consolidated total liabilities and contributed $94 million to the Company's consolidated cash from operations in 2016.
